(NASDAQ: ALGN) Align Technology's forecast annual revenue growth rate of 3.96% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.21%.
Align Technology's revenue in 2026 is $4,139,532,000.On average, 21 Wall Street analysts forecast ALGN's revenue for 2026 to be $301,990,410,852, with the lowest ALGN revenue forecast at $287,214,121,636, and the highest ALGN revenue forecast at $312,504,308,948. On average, 21 Wall Street analysts forecast ALGN's revenue for 2027 to be $314,422,384,952, with the lowest ALGN revenue forecast at $297,941,139,288, and the highest ALGN revenue forecast at $329,340,753,872.
In 2028, ALGN is forecast to generate $331,329,869,728 in revenue, with the lowest revenue forecast at $310,444,153,240 and the highest revenue forecast at $355,199,260,000.